Interestingly, patients negative for anti-AQP-4, but positive for anti-MOG antibodies fulfil many of the clinical and radiological criteria for NMO, but their relapse biology and prognosis rather resembles MS [63]. This evidence concerns the gene AQP4 and neuromyelitis optica.